Detection kit of paclitaxel metabolism marker and detection method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 湖南菲思特精准医疗科技有限公司
- Publication Date
- 2021-11-02
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a paclitaxel metabolic marker detection kit, a detection method and an application thereof, and belongs to the field of gene detection. Background technique
[0002] Paclitaxel, a natural anticancer drug, as a diterpene alkaloid compound with anticancer activity, has been widely used clinically in the treatment of breast cancer, ovarian cancer, some head and neck cancers and lung cancer. Microtubules, a component of eukaryotic cells, are formed by dimers of microtubules composed of two similar polypeptide (a and p) subunits. Under normal conditions, there is a dynamic equilibrium between microtubules and tubulin dimers. Paclitaxel can lose this dynamic balance between the two, induce and promote tubulin polymerization, prevent depolymerization, and stabilize microtubules. Paclitaxel inhibits the normal dynamic regeneration of the microtubule network necessary for mitosis, prevents the formation of the normal mitotic spindle, ...